Atlas Trials

Pirtobrutinib Maintenance After CAR-T Therapy in Relapsed or Refractory B-Cell Lymphoma

Clinical trial NCT07622784 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07622784
Sponsor
Sun Yat-sen University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Relapsed or Refractory B-cell Lymphoma
Start date
2026-06-01
Primary completion
2028-06-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.